Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: The Memorial Sloan-Kettering experience Journal Article


Authors: Dunkel, I. J.; Gerald, W. L.; Rosenfield, N. S.; Strong, E. W.; Abramson, D. H.; Ghavimi, F.
Article Title: Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: The Memorial Sloan-Kettering experience
Abstract: Background. Patients with bilateral retinoblastoma are well recognized to have a high risk of developing a second malignancy, but there are little published data regarding the outcome of these patients following treatment. Patients and Methods. We identified 15 patients with a history of bilateral retinoblastoma who received treatment at Memorial Sloan-Kettering Cancer Center for a newly diagnosed second malignancy. The median age of second tumor occurrence was 18 years (range 10-32 years). Three patients later had a third tumor (18 tumors total). Tumor sites included facial structures in 14 cases and extremities in 4. Histologies included osteosarcoma (5), leiomyosarcoma (5), high-grade spindle cell sarcoma (3), malignant fibrous histiocytoma (3), malignant mesenchymoma (1), and angiosarcoma (1). Results. Nine patients are alive: 7 disease free at a median of 29 months (range 6-214 months) and 2 with residual disease 59 and 148 months post-diagnosis of the second malignancy. Six patients have died at a median of 31 months (range 16-98 months) after diagnosis of the second malignancy. Conclusions. Patients with a history of bilateral retinoblastoma who develop a second malignancy may enjoy extended periods of survival. Aggressive therapy appropriate to the tumor histology and site is indicated. (C) 1998 Wiley-Liss, Inc.
Keywords: chemotherapy, adjuvant; neoplasms; retinoblastoma; survivors; surgery; radiation therapy; children; childhood-cancer; 2nd primary tumors; bone sarcomas; neoplasm, second primary
Journal Title: Medical and Pediatric Oncology
Volume: 30
Issue: 1
ISSN: 0098-1532
Publisher: Wiley Liss  
Date Published: 1998-01-01
Start Page: 59
End Page: 62
Language: English
ACCESSION: WOS:A1998YD97900014
DOI: 10.1002/(sici)1096-911x(199801)30:1<59::aid-mpo14>3.0.co;2-3
PROVIDER: wos
PUBMED: 9371391
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel
  2. Nancy S Rosen
    28 Rosen
  3. William L Gerald
    375 Gerald
  4. David H Abramson
    389 Abramson
  5. Elliot W Strong
    97 Strong
  6. Fereshteh   Ghavimi
    30 Ghavimi